Cabaletta Bio Inc (CABA)
10.17
+0.24
(+2.42%)
USD |
NASDAQ |
May 31, 16:00
10.17
0.00 (0.00%)
After-Hours: 20:00
Cabaletta Bio Cash and Short Term Investments (Annual): 241.25M for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 241.25M |
| December 31, 2022 | 106.55M |
| December 31, 2021 | 122.22M |
| December 31, 2020 | 108.66M |
| Date | Value |
|---|---|
| December 31, 2019 | 136.20M |
| December 31, 2018 | 33.02M |
| December 31, 2017 | 0.001M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
106.55M
Minimum
2022
241.25M
Maximum
2023
142.98M
Average
122.22M
Median
2021
Cash and Short Term Investments (Annual) Benchmarks
| Editas Medicine Inc | 323.11M |
| ACADIA Pharmaceuticals Inc | 438.86M |
| Alnylam Pharmaceuticals Inc | 2.439B |
| Regeneron Pharmaceuticals Inc | 10.84B |
| Vertex Pharmaceuticals Inc | 11.22B |